Posterior Reversible Encephalopathy Syndrome in Ischaemic Stroke with Malignant Hypertension, Chronic Kidney Disease, And Septic : A Case Report

Main Article Content

Locoporta Agung
Dodik Tugasworo
Retnaningsih
Sunarto
Dwi Rachmawati
Roynikko
Yoris Junanto

Abstract

Posterior Reversible Encephalopathy Syndrome (PRES) is a diagnosis based on neuroimaging with the finding of vasogenic edema, especially in the occipital and parietal lobes. Some of the risk factors include malignant hypertension, chronic kidney failure, organ transplantation, autoimmune, immunosuppressant drugs, chemotherapy, and sepsis. The PRES mechanism is due to disrupted autoregulation, especially in the posterior circulation which is associated with hypertension and hypoperfusion. This will cause damage to the blood-brain barrier and vasogenic edema. We report a woman, 70 years old, with the chief complaint of loss of consciousness accompanied by headache, vomiting, and restlessness. The patient has chronic hypertension and routine hemodialysis due to chronic kidney failure. On physical examination, the patient was somnolent, malignant hypertension, and hemiparesis sinistra. Imaging examination showed vasogenic edema of the right parietooccipital lobe. The patient was treated in the intensive care unit, given intravenous dexamethasone, antihypertension, antibiotic, and routine hemodialysis. Consciousness gradually improved.

Article Details

How to Cite
Agung, L., Tugasworo, D., Retnaningsih, Sunarto, Rachmawati, D., Roynikko, & Junanto, Y. (2023). Posterior Reversible Encephalopathy Syndrome in Ischaemic Stroke with Malignant Hypertension, Chronic Kidney Disease, And Septic : A Case Report. International Journal of Medical Science and Clinical Research Studies, 3(10), 2532–2537. https://doi.org/10.47191/ijmscrs/v3-i10-76
Section
Articles

References

I. Ando Y, Ono Y, Sano A, Fujita N, Ono S. Posterior Reversible Encephalopathy Syndrome: A Review of the Literature. Intern Med. 2022 Jan 15;61(2):135-141.

doi: 10.2169/internalmedicine.7520-21. Epub 2021 Jul 17.

II. Hinduja A. Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome. Front Neurol. 2020 Feb 14;11:71.

doi: 10.3389/fneur.2020.00071.

III. Adetiloye AO, Valencia Manrique J, Victoria A, Haider H, Al-Juboori MT. Posterior Reversible Encephalopathy Syndrome Presenting Atypically as a Non-Convulsive Seizure. Am J Case Rep. 2021 Nov 5;22:e933667.

doi: 10.12659/AJCR.933667.

IV. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-1616. doi: 10.1007/s00415-016-8377-8. Epub 2017 Jan 4.

V. How J, Blattner M, Fowler S, Wang-Gillam A, Schindler SE. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. Neurologist. 2016 Nov;21(6):112-117.

doi: 10.1097/NRL.0000000000000105.

VI. Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer. Oncologist. 2015 Jul;20(7):806-11. doi: 10.1634/theoncologist.2014-0149. Epub 2015 Jun 1.

VII. Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr. 2020 Sep 11;8:585. doi: 10.3389/fped.2020.00585.

VIII. Koksel Y, McKinney AM. Potentially Reversible and Recognizable Acute Encephalopathic Syndromes: Disease Categorization and MRI Appearances. AJNR Am J Neuroradiol. 2020 Aug;41(8):1328-1338. doi: 10.3174/ajnr.A6634. Epub 2020 Jul 2.

IX. Algahtani H, Algahtani A, Aldarmahi A, Hmoud M, Marzuk Y, Shirah B. Posterior Reversible Encephalopathy Syndrome: Local Experience From Saudi Arabia. Neurohospitalist. 2017 Jan;7(1):24-29. doi: 10.1177/1941874416665762. Epub 2016 Aug 31

X. Nakamura Y, Sugino M, Tsukahara A, Nakazawa H, Yamamoto N, Arawaka S. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review. BMC Neurol. 2018 Nov 12;18(1):190. doi: 10.1186/s12883-018-1194-1.

XI. Ansari B, Saadatnia M. Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran. Adv Biomed Res. 2021 Dec 25;10:53. doi: 10.4103/abr.abr_243_19.

XII. Ou S, Xia L, Wang L, Xia L, Zhou Q, Pan S. Posterior Reversible Encephalopathy Syndrome With Isolated Involving Infratentorial Structures. Front Neurol. 2018 Oct 9;9:843. doi: 10.3389/fneur.2018.00843.

XIII. Cheng X, Li J, Lan Y, Liu J, Chen S, Lu G. Cerebrovascular Disease in the Setting of Posterior Reversible Encephalopathy Syndrome. Front Neurol. 2021 Nov 17;12:765333. doi: 10.3389/fneur.2021.765333.

XIV. Alshami A, Al-Bayati A, Douedi S, Hossain MA, Patel S, Asif A. Clinical characteristics and outcomes of patients admitted to hospitals for posterior reversible encephalopathy syndrome: a retrospective cohort study. BMC Neurol. 2021 Mar 9;21(1):107. doi: 10.1186/s12883-021-02143-6.

XV. Seitz A, Parauda SC, Salehi Omran S, Schweitzer AD, Liberman AL, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H, Zhang C, Parikh NS. Long-term risk of seizure after posterior reversible encephalopathy syndrome. Ann Clin Transl Neurol. 2023 Apr;10(4):610-618. doi: 10.1002/acn3.51748. Epub 2023 Feb 22.

XVI. Bansal S, Bansal R, Goyal MK, Takkar A, Singh R, Singh P, Lal V. Clinical, Etiological and Imaging Profile of Posterior Reversible Encephalopathy Syndrome: A Prospective and Follow-Up Study. Ann Indian Acad Neurol. 2020 Mar-Apr;23(2):182-188.

doi: 10.4103/aian.AIAN_379_18. Epub 2020 Feb 25.

XVII. Çamlıdağ İ, Cho YJ, Park M, Lee SK. Atypical Unilateral Posterior Reversible Encephalopathy Syndrome Mimicking a Middle Cerebral Artery Infarction. Korean J Radiol. 2015 Sep-Oct;16(5):1104-8.

doi: 10.3348/kjr.2015.16.5.1104. Epub 2015 Aug 21.

XVIII. Ali K, Karan A, Biswah S, Teelucksingh S, Mohammed NB. Posterior Reversible Encephalopathy Syndrome: Tips for Diagnosis and Treatment. Cureus. 2021 Mar 24;13(3):e14087. doi: 10.7759/cureus.14087.

XIX. Shieh A, Darro N. Recurrent Posterior Reversible Encephalopathy Syndrome in an Adolescent Boy with End-Stage Renal Disease. Case Rep Pediatr. 2021 Feb 16;2021:6675454.

doi: 10.1155/2021/6675454.

XX. Garner O, Ramirez A, Iardino A. A case of posterior reversible encephalopathy syndrome associated with sepsis. BMJ Case Rep. 2018 Jul 10;2018:bcr2018225128. doi: 10.1136/bcr-2018-225128.

XXI. Iftikhar S, Rehman AU, Ameer MZ, Nawaz A, Aemaz Ur Rehman M, Farooq H, Asmar A, Ebaad Ur Rehman M. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review. Ann Med Surg (Lond). 2021 Dec;72:103080. doi: 10.1016/j.amsu.2021.103080. Epub 2021 Nov 20.

XXII. Parikh NS, Schweitzer AD, Young RJ, Giambrone AE, Lyo J, Karimi S, Knobel A, Gupta A, Navi BB. Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome. J Neurol Sci. 2017 Sep 15;380:11-15. doi: 10.1016/j.jns.2017.06.044. Epub 2017 Jun 29.

XXIII. Chen Z, Zhang G, Lerner A, Wang AH, Gao B, Liu J. Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis. Quant Imaging Med Surg. 2018 May;8(4):421-432.

doi: 10.21037/qims.2018.05.07.

XXIV. Thompson RJ, Sharp B, Pothof J, Hamedani A. Posterior reversible encephalopathy syndrome in the emergency department: case series and literature review. West J Emerg Med. 2015 Jan;16(1):5-10.

doi: 10.5811/westjem.2014.12.24126. Epub 2015 Jan 5.